
Global Cardiovascular Health Products Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Cardiovascular Health Products market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Cardiovascular Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Cardiovascular Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Cardiovascular Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Cardiovascular Health Products include Medtronic, Zhe Jiang Hua Hai Pharmaceutical, Philips, Siemens Healthineers, Johnson & Johnson, Boston Scientific and Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Health Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Health Products.
The Cardiovascular Health Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular Health Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Cardiovascular Health Products Segment by Company
Medtronic
Zhe Jiang Hua Hai Pharmaceutical
Philips
Siemens Healthineers
Johnson & Johnson
Boston Scientific
Abbott Laboratories
Cardiovascular Health Products Segment by Type
Oral Health Products
Injectable Health Products
Cardiovascular Health Products Segment by Application
Daily Use
Postoperative Use
Therapeutic Use
Cardiovascular Health Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Health Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cardiovascular Health Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Cardiovascular Health Products market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Cardiovascular Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Cardiovascular Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Cardiovascular Health Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Cardiovascular Health Products include Medtronic, Zhe Jiang Hua Hai Pharmaceutical, Philips, Siemens Healthineers, Johnson & Johnson, Boston Scientific and Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Health Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Health Products.
The Cardiovascular Health Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular Health Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Cardiovascular Health Products Segment by Company
Medtronic
Zhe Jiang Hua Hai Pharmaceutical
Philips
Siemens Healthineers
Johnson & Johnson
Boston Scientific
Abbott Laboratories
Cardiovascular Health Products Segment by Type
Oral Health Products
Injectable Health Products
Cardiovascular Health Products Segment by Application
Daily Use
Postoperative Use
Therapeutic Use
Cardiovascular Health Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Health Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cardiovascular Health Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
91 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cardiovascular Health Products Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Cardiovascular Health Products Sales Estimates and Forecasts (2020-2031)
- 1.3 Cardiovascular Health Products Market by Type
- 1.3.1 Oral Health Products
- 1.3.2 Injectable Health Products
- 1.4 Global Cardiovascular Health Products Market Size by Type
- 1.4.1 Global Cardiovascular Health Products Market Size Overview by Type (2020-2031)
- 1.4.2 Global Cardiovascular Health Products Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Cardiovascular Health Products Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cardiovascular Health Products Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Cardiovascular Health Products Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Cardiovascular Health Products Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Cardiovascular Health Products Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Cardiovascular Health Products Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Cardiovascular Health Products Industry Trends
- 2.2 Cardiovascular Health Products Industry Drivers
- 2.3 Cardiovascular Health Products Industry Opportunities and Challenges
- 2.4 Cardiovascular Health Products Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cardiovascular Health Products Revenue (2020-2025)
- 3.2 Global Top Players by Cardiovascular Health Products Sales (2020-2025)
- 3.3 Global Top Players by Cardiovascular Health Products Price (2020-2025)
- 3.4 Global Cardiovascular Health Products Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Cardiovascular Health Products Major Company Production Sites & Headquarters
- 3.6 Global Cardiovascular Health Products Company, Product Type & Application
- 3.7 Global Cardiovascular Health Products Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cardiovascular Health Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cardiovascular Health Products Players Market Share by Revenue in 2024
- 3.8.3 2023 Cardiovascular Health Products Tier 1, Tier 2, and Tier 3
- 4 Cardiovascular Health Products Regional Status and Outlook
- 4.1 Global Cardiovascular Health Products Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Cardiovascular Health Products Historic Market Size by Region
- 4.2.1 Global Cardiovascular Health Products Sales in Volume by Region (2020-2025)
- 4.2.2 Global Cardiovascular Health Products Sales in Value by Region (2020-2025)
- 4.2.3 Global Cardiovascular Health Products Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Cardiovascular Health Products Forecasted Market Size by Region
- 4.3.1 Global Cardiovascular Health Products Sales in Volume by Region (2026-2031)
- 4.3.2 Global Cardiovascular Health Products Sales in Value by Region (2026-2031)
- 4.3.3 Global Cardiovascular Health Products Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Cardiovascular Health Products by Application
- 5.1 Cardiovascular Health Products Market by Application
- 5.1.1 Daily Use
- 5.1.2 Postoperative Use
- 5.1.3 Therapeutic Use
- 5.2 Global Cardiovascular Health Products Market Size by Application
- 5.2.1 Global Cardiovascular Health Products Market Size Overview by Application (2020-2031)
- 5.2.2 Global Cardiovascular Health Products Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Cardiovascular Health Products Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cardiovascular Health Products Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Cardiovascular Health Products Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Cardiovascular Health Products Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Cardiovascular Health Products Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Cardiovascular Health Products Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Comapny Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Medtronic Cardiovascular Health Products Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Zhe Jiang Hua Hai Pharmaceutical
- 6.2.1 Zhe Jiang Hua Hai Pharmaceutical Comapny Information
- 6.2.2 Zhe Jiang Hua Hai Pharmaceutical Business Overview
- 6.2.3 Zhe Jiang Hua Hai Pharmaceutical Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Zhe Jiang Hua Hai Pharmaceutical Cardiovascular Health Products Product Portfolio
- 6.2.5 Zhe Jiang Hua Hai Pharmaceutical Recent Developments
- 6.3 Philips
- 6.3.1 Philips Comapny Information
- 6.3.2 Philips Business Overview
- 6.3.3 Philips Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Philips Cardiovascular Health Products Product Portfolio
- 6.3.5 Philips Recent Developments
- 6.4 Siemens Healthineers
- 6.4.1 Siemens Healthineers Comapny Information
- 6.4.2 Siemens Healthineers Business Overview
- 6.4.3 Siemens Healthineers Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Siemens Healthineers Cardiovascular Health Products Product Portfolio
- 6.4.5 Siemens Healthineers Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Comapny Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Johnson & Johnson Cardiovascular Health Products Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 Boston Scientific
- 6.6.1 Boston Scientific Comapny Information
- 6.6.2 Boston Scientific Business Overview
- 6.6.3 Boston Scientific Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Boston Scientific Cardiovascular Health Products Product Portfolio
- 6.6.5 Boston Scientific Recent Developments
- 6.7 Abbott Laboratories
- 6.7.1 Abbott Laboratories Comapny Information
- 6.7.2 Abbott Laboratories Business Overview
- 6.7.3 Abbott Laboratories Cardiovascular Health Products Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Abbott Laboratories Cardiovascular Health Products Product Portfolio
- 6.7.5 Abbott Laboratories Recent Developments
- 7 North America by Country
- 7.1 North America Cardiovascular Health Products Sales by Country
- 7.1.1 North America Cardiovascular Health Products Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Cardiovascular Health Products Sales by Country (2020-2025)
- 7.1.3 North America Cardiovascular Health Products Sales Forecast by Country (2026-2031)
- 7.2 North America Cardiovascular Health Products Market Size by Country
- 7.2.1 North America Cardiovascular Health Products Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Cardiovascular Health Products Market Size by Country (2020-2025)
- 7.2.3 North America Cardiovascular Health Products Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Cardiovascular Health Products Sales by Country
- 8.1.1 Europe Cardiovascular Health Products Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Cardiovascular Health Products Sales by Country (2020-2025)
- 8.1.3 Europe Cardiovascular Health Products Sales Forecast by Country (2026-2031)
- 8.2 Europe Cardiovascular Health Products Market Size by Country
- 8.2.1 Europe Cardiovascular Health Products Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Cardiovascular Health Products Market Size by Country (2020-2025)
- 8.2.3 Europe Cardiovascular Health Products Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cardiovascular Health Products Sales by Country
- 9.1.1 Asia-Pacific Cardiovascular Health Products Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Cardiovascular Health Products Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Cardiovascular Health Products Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Cardiovascular Health Products Market Size by Country
- 9.2.1 Asia-Pacific Cardiovascular Health Products Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Cardiovascular Health Products Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Cardiovascular Health Products Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Cardiovascular Health Products Sales by Country
- 10.1.1 South America Cardiovascular Health Products Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Cardiovascular Health Products Sales by Country (2020-2025)
- 10.1.3 South America Cardiovascular Health Products Sales Forecast by Country (2026-2031)
- 10.2 South America Cardiovascular Health Products Market Size by Country
- 10.2.1 South America Cardiovascular Health Products Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Cardiovascular Health Products Market Size by Country (2020-2025)
- 10.2.3 South America Cardiovascular Health Products Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cardiovascular Health Products Sales by Country
- 11.1.1 Middle East and Africa Cardiovascular Health Products Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Cardiovascular Health Products Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Cardiovascular Health Products Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Cardiovascular Health Products Market Size by Country
- 11.2.1 Middle East and Africa Cardiovascular Health Products Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Cardiovascular Health Products Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Cardiovascular Health Products Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Cardiovascular Health Products Value Chain Analysis
- 12.1.1 Cardiovascular Health Products Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cardiovascular Health Products Production Mode & Process
- 12.2 Cardiovascular Health Products Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cardiovascular Health Products Distributors
- 12.2.3 Cardiovascular Health Products Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.